The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Efficacy of antidepressants: bias in randomized clinical trials and related issues
Abstract
Introduction Countless antidepressant randomized trials were conducted and showed statistically significant benefits of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) over placebo. Meanwhile, critics are increasing regarding the efficacy of antidepressants in the treatment of MDD because at least a proportion of clinical trials could be hampered by various biases. In contrast, number of failed trials is increasing in the recent years which have made developing psychiatric medications progressively more time-consuming and expensive. Areas covered: Biases and related issues in clinical trials for antidepressants can be identified as an important common contributing factor to the two paradoxical phenomenon. This review identifies possible biases that can occur before, during, and after clinical trials of antidepressant. Expert commentary: Recent studies not only may over-estimate efficacy of antidepressants, but also may exaggerate placebo response because of various biases. Sponsorship and publication biases have been one of the targets of the criticism and ethical debate. Thus, initiating new trend of research by re-organizing academic-industry partnership will be the most important task in the next five years.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although SSRIs and serotonin-norepinephrine reuptake inhibitor (SNRIs) perform better than placebo at reducing symptoms of depression188, 189, there are weeks-long lag time in attaining full benefit and many patients do not respond.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [188]
In the citing paper
“Although SSRIs and serotonin-norepinephrine reuptake inhibitor (SNRIs) perform better than placebo at reducing symptoms of depression188, 189, there are weeks-long lag time in attaining full benefit and many patients do not respond.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [188]
In the citing paper
“Although SSRIs and serotonin-norepinephrine reuptake inhibitor (SNRIs) perform better than placebo at reducing symptoms of depression188, 189, there are weeks-long lag time in attaining full benefit and many patients do not respond.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [188]
In the citing paper
“Various biases could have resulted in discrepancies between results from RCT and naturalistic studies.”
From Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review (2018) · cites this paper as [105]
Citations
Cites
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009
Regression to the mean: what it is and how to deal with it
Barnett, A. G. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh299 · Cited by 1,988 · cited 1×
“One important related bias is called regression to the mean, which is a statistical phenomenon stating that data that are extremely higher or lower than the mean will likely be closer to the mean if it is measured a second time [74].”
BackgroundThe Hawthorne Effect: a randomised, controlled trial
McCarney, R., Warner, J., Iliffe, S., van Haselen, R., Griffin, M., & Fisher, P. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-30 · Cited by 1,715
Language bias in randomised controlled trials published in English and German
Egger, M., Zellweger-Zähner, T., Schneider, M., Junker, C., Lengeler, C., & Antes, G. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02419-7 · Cited by 1,028
D'Agostino, R. B., Massaro, J. M., & Sullivan, L. M. (2003) · Statistics in Medicine · doi:10.1002/sim.1425 · Cited by 715
The Placebo Effect: Dissolving the Expectancy Versus Conditioning Debate.
Stewart-Williams, S., & Podd, J. (2004) · Psychological Bulletin · doi:10.1037/0033-2909.130.2.324 · Cited by 664
Statistical Considerations in the Intent-to-Treat Principle
Lachin, J. M. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00046-5 · Cited by 652 · cited 1×
“evaluation on the basis of the ITT a subject rather than the actual treatment given [32].”
Background
Research works printed but not linked: 5
- 10.1192/bjp.183.6.498 · doi:10.1192/bjp.183.6.498 · Paper page
- Kirsch I, 2014, Z Psychol, 222, 128
- Stettin GD, 2006, Am J Manag Care, 12, 453
- Bass MJ, 1986, J Fam Pract, 23, 43
- Friedman JH, 2004, Med Health R I, 87, 262
Cited by
Tartt, A. N., Mariani, M. B., Hen, R., Mann, J. J., & Boldrini, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01520-y · Cited by 408
“Although SSRIs and serotonin-norepinephrine reuptake inhibitor perform better than placebo at reducing symptoms of depression [187, 188], there are weeks-long lag time in attaining Untreated Depression Treated Depression”
BackgroundAddressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299
Self-citationBraslow, J. T., & Marder, S. R. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050718-095514 · Cited by 122
What Is New about New Antidepressants?
Dubovsky, S. L. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000488945 · Cited by 37
Metadata
- Authors
- Wang, S.-M., Han, C., Lee, S.-J., Jun, T.-Y., Patkar, A. A., Masand, P. S., & Pae, C.-U.
- Affiliations
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Korea University (KR)
- Catholic University of Korea (KR)
- Duke Medical Center (US)
- Global Medical Education, New York, NY, USA
- Corresponding author
- Pae, Chi-Un
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2017-09-14
- Volume
- 11
- Issue
- 1
- Pages
- 15-25
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- OpenAlex
- W2754151110
- Cited by
- 20
- References
- 90
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2019: 7 · 2018: 3
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Review of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) (HC15C1405)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Keywords
- antidepressants, antidepressant efficacy, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, major depressive disorder, trial bias, placebo response, publication bias, sponsorship bias, university-industry collaboration, clinical trial failure, psychiatric drug development
- MeSH terms
- Serotonin and Noradrenaline Reuptake Inhibitors, Antidepressive Agents, Major Depressive Disorder, Humans, Bias, Placebo Effect, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Publication Bias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of antidepressants: bias in randomized clinical trials and related issues. https://app.cochat.ai/papers/10.1080/17512433.2017.1377070
- The paper
- Wang, S.-M., Han, C., Lee, S.-J., Jun, T.-Y., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018). Efficacy of antidepressants: bias in randomized clinical trials and related issues. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2017.1377070
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.